Barclays Downgrades Cincor Pharma Inc (CINC) to Equalweight

January 12, 2023 3:40 AM EST Send to a Friend
Barclays analyst Leon Wang downgraded Cincor Pharma Inc (NASDAQ: CINC) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login